SAM
EPRS

Solaris Asset Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Solaris Asset Management’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-91
Closed – – 226
2017
Q4 		$0 Hold
91
– – ﹤0.01% 292
2017
Q3 		$0 Hold
91
– – ﹤0.01% 321
2017
Q2 		$0 Hold
91
– – ﹤0.01% 323
2017
Q1 		$0 Buy
+91
New – ﹤0.01% 300

Solaris Asset Management's EPRS Position: Q1 2018 in Review

Solaris Asset Management sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q1 2018, closing a stake of 91 shares.

Solaris Asset Management first reported a position in EPRS in Q1 2017 and held it in 4 quarters. The position peaked at $0 in Q4 2017. 0 funds tracked by Wall St. Rank hold EPRS as of Q1 2018.

  • Solaris Asset Management reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q1 2018 after selling out during the quarter.
  • Solaris Asset Management sold 91 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q1 2018.
  • Solaris Asset Management first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2017 and held it in 4 quarters.
  • Solaris Asset Management's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $0 in Q4 2017.
  • 0 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.